Han Cun-zhi, Shi Jing, Du Li-li, Jing Jie-xian, Zhao Xian-wen, Tian Bao-guo, Tian Fu-guo, Liu Xiu-ying, Zhang Zhong-shu, Zhang Jin
Department of Etiology, Shanxi Cancer Institute, Taiyuan 030013, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Feb;28(2):136-40.
To evaluate the association between serum level of leptin and leptin receptor gene (LEPR) polymorphism and patients with breast cancer.
LEPR G1n223Arg polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism in 94 patients with breast cancer and 128 healthy controls. The level of leptin were analyzed by enzyme linked immunosorbent assay.
In univariate regression analyses, we found serum level of leptin and LEPR Gin223Arg genotype polymorphism were significantly higrer than those of the controls (P < 0.05-0.001, respectively). Through multivariable analyses, we found that increased risk estimates for breast cancer were among those with leptin level (OR = 1.53, 95% CI: 1.13-2.07, P = 0.006), LEPR Gin223Arg genotype (OR = 4.87, 95%CI:1.30-18.22, P = 0.019), WHR (OR = 3.68, 95% CI: 1.34-10.11, P = 0.011).
Results from this study suggested that LEPR Gln233Agr polymorphism, the elevated WHR and serum level of leptin might be correlated with increased risk of breast cancer.
评估血清瘦素水平及瘦素受体基因(LEPR)多态性与乳腺癌患者之间的关联。
采用聚合酶链反应-限制性片段长度多态性方法检测94例乳腺癌患者和128例健康对照者的LEPR G1n223Arg多态性。采用酶联免疫吸附测定法分析瘦素水平。
在单因素回归分析中,我们发现乳腺癌患者的血清瘦素水平和LEPR Gin223Arg基因型多态性显著高于对照组(分别为P < 0.05 - 0.001)。通过多因素分析,我们发现乳腺癌风险增加的估计值存在于瘦素水平较高者(OR = 1.53,95%CI:1.13 - 2.07,P = 0.006)、LEPR Gin223Arg基因型者(OR = 4.87,95%CI:1.30 - 18.22,P = 0.019)、腰臀比(WHR)较高者(OR = 3.68,95%CI:1.34 - 10.11,P = 0.011)中。
本研究结果表明,LEPR Gln233Agr多态性、升高的WHR和血清瘦素水平可能与乳腺癌风险增加相关。